Matthew K Ito

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. doi request reprint Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study
    Matthew K Ito
    Oregon State University Oregon Health and Science University College of Pharmacy, 3303 SW Bond Avenue, Portland, OR 97239, USA Electronic address
    J Clin Lipidol 8:69-76. 2014
  2. doi request reprint Dyslipidemia: management using optimal lipid-lowering therapy
    Matthew K Ito
    College of Pharmacy, Oregon State University Oregon Health and Science University, Portland, USA
    Ann Pharmacother 46:1368-81. 2012
  3. ncbi request reprint Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias--2005
    Matthew K Ito
    College of Pharmacy, Oregon State University, Portland Program at Oregon Health and Science University, Portland, Oregon 97239 3098, USA
    Pharmacotherapy 26:939-1010. 2006
  4. ncbi request reprint ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?
    Matthew K Ito
    College of Pharmacy, Oregon State University Oregon Health and Science University, Portland Campus at OHSU, 3303 SW Bond Ave, Portland, OR 97239, USA
    Ann Pharmacother 41:1669-78. 2007
  5. doi request reprint What combination therapy with a statin, if any, would you recommend?
    Carlos A Dujovne
    Division of Cardiovascular Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Curr Atheroscler Rep 13:12-22. 2011
  6. ncbi request reprint Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction
    Matthew K Ito
    University of California, San Diego School of Medicine, La Jolla, California, USA
    Pharmacotherapy 26:85S-97S; discussion 98S-101S; quiz 106S-108S. 2006

Detail Information

Publications6

  1. doi request reprint Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study
    Matthew K Ito
    Oregon State University Oregon Health and Science University College of Pharmacy, 3303 SW Bond Avenue, Portland, OR 97239, USA Electronic address
    J Clin Lipidol 8:69-76. 2014
    ..Drug interactions have been identified as a risk factor for muscle-related side effects in statin users...
  2. doi request reprint Dyslipidemia: management using optimal lipid-lowering therapy
    Matthew K Ito
    College of Pharmacy, Oregon State University Oregon Health and Science University, Portland, USA
    Ann Pharmacother 46:1368-81. 2012
    ..To evaluate current approaches and explore emerging research related to dyslipidemia management...
  3. ncbi request reprint Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias--2005
    Matthew K Ito
    College of Pharmacy, Oregon State University, Portland Program at Oregon Health and Science University, Portland, Oregon 97239 3098, USA
    Pharmacotherapy 26:939-1010. 2006
    ..Research articles were chosen based on the significance of findings, relevance to practice, quality of research, and timeliness; recent articles were given priority over earlier ones unless they demonstrated groundbreaking findings...
  4. ncbi request reprint ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?
    Matthew K Ito
    College of Pharmacy, Oregon State University Oregon Health and Science University, Portland Campus at OHSU, 3303 SW Bond Ave, Portland, OR 97239, USA
    Ann Pharmacother 41:1669-78. 2007
    ....
  5. doi request reprint What combination therapy with a statin, if any, would you recommend?
    Carlos A Dujovne
    Division of Cardiovascular Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Curr Atheroscler Rep 13:12-22. 2011
    ....
  6. ncbi request reprint Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction
    Matthew K Ito
    University of California, San Diego School of Medicine, La Jolla, California, USA
    Pharmacotherapy 26:85S-97S; discussion 98S-101S; quiz 106S-108S. 2006
    ....